Trade XLO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Xilio Therapeutics, Inc. (XLO) is trading at US$9.08, up 0.28% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$60.73M. Over the past 52 weeks, XLO has traded between US$6.47 and US$12.58. On Syfe you can trade XLO with $0 commission and add it to your watchlist.
| Previous close | US$9.05 |
|---|---|
| Market cap | US$60.73M |
| 52-week range | US$6.47 – US$12.58 |
| Volume | 8.39K |
| Exchange | US |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Year: 2021
Xilio Therapeutics, Inc. (XLO) stock is trading at US$9.08, +0.28% from the previous close of US$9.05.
The market cap for Xilio Therapeutics, Inc. (XLO) stock is approximately US$60.73M.
The 52-week high for Xilio Therapeutics, Inc. (XLO) stock is US$12.58.
The 52-week low for Xilio Therapeutics, Inc. (XLO) stock is US$6.47.
Xilio Therapeutics, Inc. (XLO) does not currently pay a dividend.
Stay on top of XLO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
